Fig. 4From: Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patientsKaplan–Meier curve for injection-free duration after the loading doses of brolucizumab and afliberceptBack to article page